Interventions for Tobacco Cessation in Adults, including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

JAMA - Journal of the American Medical Association

Volumn 325, Issue 3, 2021, Pages 280-298

  Patnode, Carrie D ^a   Henderson, Jillian T ^a   Coppola, Erin L ^a   Melnikow, Joy ^b   Durbin, Shauna ^b   Thomas, Rachel G ^a  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; PLACEBO; VARENICLINE;

ADULT; ALL CAUSE MORTALITY; BRONCHOALVEOLAR LAVAGE FLUID; CIGARETTE SMOKING; CLINICIAN; COUGHING; DEPRESSION; EVIDENCE BASED PRACTICE; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HOUSEHOLD INCOME; HUMAN; INSOMNIA; LUNG FUNCTION; META ANALYSIS; NAUSEA; PASSIVE SMOKING; PATIENT COUNSELING; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; SUDDEN INFANT DEATH SYNDROME; SUICIDAL IDEATION; SYSTEMATIC REVIEW; TEXT MESSAGING; THROAT IRRITATION; TOBACCO USE; VOMITING; ADVERSE EVENT; BEHAVIOR THERAPY; ELECTRONIC CIGARETTE; MALE; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PREGNANCY; PRIMARY HEALTH CARE; PROCEDURES; TOBACCO DEPENDENCE;

ADULT; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRIMARY HEALTH CARE; SMOKING CESSATION; SMOKING CESSATION AGENTS; TOBACCO USE CESSATION; TOBACCO USE CESSATION DEVICES; TOBACCO USE DISORDER;

EID: 85099559499     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2020.23541     Document Type: Review

References (120)

1. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults-United States, 2019. MMWR Morb Mortal Wkly Rep. 2020; 69 (46): 1736-1742. doi: 10.15585/mmwr.mm6946a4 33211681
2. US Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
3. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults-United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017; 65 (52): 1457-1464. doi: 10.15585/mmwr.mm6552a1 28056007
4. Siu AL; US Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 163 (8): 622-634. doi: 10.7326/M15-2023 26389730
5. Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2015; 163 (8): 608-621. doi: 10.7326/M15-0171 26389650
6. Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality; 2015.
7. Procedure Manual. US Preventive Services Task Force. Published 2015. Accessed May 22, 2019. https://www.uspreventiveservicestaskforce.org/uspstf/procedure-manual
8. Patnode CD, Henderson JT, Melknikow J, Coppola EL, Durbin S, Thomas R. Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 196. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05264-EF-1.
9. Shea BJ, Reeves BC, Wells G, AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358: j4008. doi: 10.1136/bmj.j4008 28935701
10. Berkman ND, Lohr KN, Ansari M, Grading the strength of a body of evidence when assessing health care interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: an update. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality; 2014: 314-349. AHRQ publication 10(14)-EHC063-EF.
11. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016; 3 (3): CD008286. doi: 10.1002/14651858.CD008286.pub3 27009521
12. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018; 5 (5): CD000146. doi: 10.1002/14651858.CD000146.pub5 29852054
13. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019; 4 (4): CD013308. doi: 10.1002/14651858.CD013308 30997928
14. Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010; 8: 8. doi: 10.1186/1617-9625-8-8 20626883
15. Howes S, Hartmann-Boyce J, Livingstone-Banks J, Hong B, Lindson N. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2020; 4 (4): CD000031. 32319681
16. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016;(5): CD006103. doi: 10.1002/14651858.CD006103.pub7 27158893
17. Agboola SA, Coleman T, McNeill A, Leonardi-Bee J. Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials. Addiction. 2015; 110 (7): 1182-1193. doi: 10.1111/add.12941 25846123
18. Sterling LH, Windle SB, Filion KB, Touma L, Eisenberg MJ. Varenicline and adverse cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016; 5 (2): e002849. doi: 10.1161/JAHA.115.002849 26903004
19. Thomas KH, Martin RM, Knipe DW, Higgins JP, Gunnell D. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 2015; 350: h1109. doi: 10.1136/bmj.h1109 25767129
20. Chang PH, Chiang CH, Ho WC, Wu PZ, Tsai JS, Guo FR. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health. 2015; 15: 689. doi: 10.1186/s12889-015-2055-0 26198192
21. Windle SB, Filion KB, Mancini JG, Combination therapies for smoking cessation: a hierarchical Bayesian meta-analysis. Am J Prev Med. 2016; 51 (6): 1060-1071. doi: 10.1016/j.amepre.2016.07.011 27617367
22. Mills EJ, Thorlund K, Eapen S, Wu P, Prochaska JJ. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014; 129 (1): 28-41. doi: 10.1161/CIRCULATIONAHA.113.003961 24323793
23. Rosen LJ, Galili T, Kott J, Goodman M, Freedman LS. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Addiction. 2018; 113 (5): 805-816. doi: 10.1111/add.14134 29377409
24. Hollands GJ, Naughton F, Farley A, Lindson N, Aveyard P. Interventions to increase adherence to medications for tobacco dependence. Cochrane Database Syst Rev. 2019; 8 (8): CD009164. doi: 10.1002/14651858.CD009164.pub3 31425618
25. Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2019; 6 (6): CD009670. doi: 10.1002/14651858.CD009670.pub4 31166007
26. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013;(5): CD000165. 23728631
27. Rice VH, Heath L, Livingstone-Banks J, Hartmann-Boyce J. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2017; 12 (12): CD001188. 29243221
28. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017; 3 (3): CD001292. 28361496
29. Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017; 3 (3): CD001007. doi: 10.1002/14651858.CD001007.pub3 28361497
30. Lindson N, Thompson TP, Ferrey A, Lambert JD, Aveyard P. Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2019; 7 (7): CD006936. 31425622
31. Denison E, Underland V, Mosdol A, Vist G. Cognitive Therapies for Smoking Cessation: A Systematic Review. Knowledge Centre for the Health Services at the Norwegian Institute of Public Health (NIPH); 2017.
32. Moyo F, Archibald E, Slyer JT. Effectiveness of decision aids for smoking cessation in adults: a quantitative systematic review. JBI Database System Rev Implement Rep. 2018; 16 (9): 1791-1822. doi: 10.11124/JBISRIR-2017-003698 30204670
33. Livingstone-Banks J, Ordóñez-Mena JM, Hartmann-Boyce J. Print-based self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 1 (1): CD001118. 30623970
34. Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019; 5 (5): CD002850. 31045250
35. Danielsson AK, Eriksson AK, Allebeck P. Technology-based support via telephone or web: a systematic review of the effects on smoking, alcohol use and gambling. Addict Behav. 2014; 39 (12): 1846-1868. doi: 10.1016/j.addbeh.2014.06.007 25128637
36. Tzelepis F, Paul CL, Williams CM, Real-time video counselling for smoking cessation. Cochrane Database Syst Rev. 2019; 2019 (10): CD012659. 31684699
37. Palmer M, Sutherland J, Barnard S, The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: a systematic review of randomised controlled trials. PLoS One. 2018; 13 (1): e0189801. doi: 10.1371/journal.pone.0189801 29304148
38. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 10 (10): CD006611. doi: 10.1002/14651858.CD006611.pub5 31638271
39. Do HP, Tran BX, Le Pham Q, Which eHealth interventions are most effective for smoking cessation? a systematic review. Patient Prefer Adherence. 2018; 12: 2065-2084. doi: 10.2147/PPA.S169397 30349201
40. McCrabb S, Baker AL, Attia J, Internet-based programs incorporating behavior change techniques are associated with increased smoking cessation in the general population: a systematic review and meta-analysis. Ann Behav Med. 2019; 53 (2): 180-195. doi: 10.1093/abm/kay026 29750240
41. Taylor GMJ, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev. 2017; 9 (9): CD007078. 28869775
42. Graham AL, Carpenter KM, Cha S, Systematic review and meta-analysis of internet interventions for smoking cessation among adults. Subst Abuse Rehabil. 2016; 7: 55-69. doi: 10.2147/SAR.S101660 27274333
43. Notley C, Gentry S, Livingstone-Banks J, Bauld L, Perera R, Hartmann-Boyce J. Incentives for smoking cessation. Cochrane Database Syst Rev. 2019; 7 (7): CD004307. 31313293
44. Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS One. 2014; 9 (3): e90347. doi: 10.1371/journal.pone.0090347 24618584
45. Clair C, Mueller Y, Livingstone-Banks J, Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev. 2019; 3 (3): CD004705. doi: 10.1002/14651858.CD004705.pub5 30912847
46. Ussher MH, Faulkner GEJ, Angus K, Hartmann-Boyce J, Taylor AH. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 2019 (10): CD002295. 31684691
47. Klinsophon T, Thaveeratitham P, Sitthipornvorakul E, Janwantanakul P. Effect of exercise type on smoking cessation: a meta-analysis of randomized controlled trials. BMC Res Notes. 2017; 10 (1): 442. doi: 10.1186/s13104-017-2762-y 28874175
48. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2014;(1): CD000009. doi: 10.1002/14651858.CD000009.pub4 24459016
49. Barnes J, McRobbie H, Dong CY, Walker N, Hartmann-Boyce J. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2019; 6: CD001008. 31198991
50. Boyle R, Solberg L, Fiore M. Use of electronic health records to support smoking cessation. Cochrane Database Syst Rev. 2014;(12): CD008743. doi: 10.1002/14651858.CD008743.pub3 25547090
51. Thomas D, Abramson MJ, Bonevski B, George J. System change interventions for smoking cessation. Cochrane Database Syst Rev. 2017; 2 (2): CD010742. 28185257
52. Lindson N, Klemperer E, Hong B, Ordóñez-Mena JM, Aveyard P. Smoking reduction interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 9 (9): CD013183. 31565800
53. Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Hajek P. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2019; 2 (2): CD003999. 30758045
54. Chamberlain C, O'Mara-Eves A, Porter J, Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017; 2 (2): CD001055. doi: 10.1002/14651858.CD001055.pub5 28196405
55. Griffiths SE, Parsons J, Naughton F, Fulton EA, Tombor I, Brown KE. Are digital interventions for smoking cessation in pregnancy effective? a systematic review and meta-analysis. Health Psychol Rev. 2018; 12 (4): 333-356. doi: 10.1080/17437199.2018.1488602 29912621
56. Wilson SM, Newins AR, Medenblik AM, Contingency management versus psychotherapy for prenatal smoking cessation: a meta-analysis of randomized controlled trials. Womens Health Issues. 2018; 28 (6): 514-523. doi: 10.1016/j.whi.2018.05.002 30061033
57. Wu L, Sun S, He Y, Zeng J. Effect of smoking reduction therapy on smoking cessation for smokers without an intention to quit: an updated systematic review and meta-analysis of randomized controlled. Int J Environ Res Public Health. 2015; 12 (9): 10235-10253. doi: 10.3390/ijerph120910235 26308034
58. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016; 11 (11): CD010274. doi: 10.1002/14651858.CD010274.pub2 27878808
59. Thurgood SL, McNeill A, Clark-Carter D, Brose LS. A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine Tob Res. 2016; 18 (5): 993-1001. doi: 10.1093/ntr/ntv127 26069036
60. Wilson A, Guillaumier A, George J, Denham A, Bonevski B. A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups (2010-2017). Expert Rev Respir Med. 2017; 11 (8): 617-630. doi: 10.1080/17476348.2017.1340836 28608758
61. Boland VC, Stockings EA, Mattick RP, McRobbie H, Brown J, Courtney RJ. The methodological quality and effectiveness of technology-based smoking cessation interventions for disadvantaged groups: a systematic review and meta-analysis. Nicotine Tob Res. 2018; 20 (3): 276-285. doi: 10.1093/ntr/ntw391 28034998
62. Liu JJ, Wabnitz C, Davidson E, Smoking cessation interventions for ethnic minority groups-a systematic review of adapted interventions. Prev Med. 2013; 57 (6): 765-775. doi: 10.1016/j.ypmed.2013.09.014 24076130
63. Johnston V, Westphal DW, Glover M, Thomas DP, Segan C, Walker N. Reducing smoking among indigenous populations: new evidence from a review of trials. Nicotine Tob Res. 2013; 15 (8): 1329-1338. doi: 10.1093/ntr/ntt022 23519776
64. Carson KV, Brinn MP, Peters M, Veale A, Esterman AJ, Smith BJ. Interventions for smoking cessation in indigenous populations. Cochrane Database Syst Rev. 2012; 1 (1): CD009046. doi: 10.1002/14651858.CD009046.pub2 22258998
65. Schuit E, Panagiotou OA, Munafò MR, Bennett DA, Bergen AW, David SP. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017; 9 (9): CD011823. doi: 10.1002/14651858.CD011823.pub2 28884473
66. Khanna P, Clifton AV, Banks D, Tosh GE. Smoking cessation advice for people with serious mental illness. Cochrane Database Syst Rev. 2016; 1 (1): CD009704. doi: 10.1002/14651858.CD009704.pub2 26816385
67. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev. 2013;(2): CD007253. doi: 10.1002/14651858.CD007253.pub3 23450574
68. van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev. 2013;(8): CD006102. doi: 10.1002/14651858.CD006102.pub2 23963776
69. Peckham E, Brabyn S, Cook L, Tew G, Gilbody S. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis. BMC Psychiatry. 2017; 17 (1): 252. doi: 10.1186/s12888-017-1419-7 28705244
70. Roberts E, Eden Evins A, McNeill A, Robson D. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction. 2016; 111 (4): 599-612. doi: 10.1111/add.13236 26594837
71. Ahmed S, Virani S, Kotapati VP, Efficacy and safety of varenicline for smoking cessation in schizophrenia: a meta-analysis. Front Psychiatry. 2018; 9: 428. doi: 10.3389/fpsyt.2018.00428 30283363
72. Kishi T, Iwata N. Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2015; 265 (3): 259-268. doi: 10.1007/s00406-014-0551-3 25283510
73. Wu Q, Gilbody S, Peckham E, Brabyn S, Parrott S. Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis. Addiction. 2016; 111 (9): 1554-1567. doi: 10.1111/add.13415 27043328
74. Smith PH, Weinberger AH, Zhang J, Emme E, Mazure CM, McKee SA. Sex differences in smoking cessation pharmacotherapy comparative efficacy: a network meta-analysis. Nicotine Tob Res. 2017; 19 (3): 273-281. 27613893
75. McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex differences in varenicline efficacy for smoking cessation: a meta-analysis. Nicotine Tob Res. 2016; 18 (5): 1002-1011. doi: 10.1093/ntr/ntv207 26446070
76. Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2015;(10): CD004306. 26501380
77. Schwartz J, Fadahunsi O, Hingorani R, Use of varenicline in smokeless tobacco cessation: a systematic review and meta-analysis. Nicotine Tob Res. 2016; 18 (1): 10-16. 25646351
78. Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016; 4: CD006611. 27060875
79. Bullen C, Williman J, Howe C, Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health. 2013; 13: 210. doi: 10.1186/1471-2458-13-210 23496861
80. Bullen C, Howe C, Laugesen M, Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382 (9905): 1629-1637. doi: 10.1016/S0140-6736(13)61842-5 24029165
81. Caponnetto P, Campagna D, Cibella F, EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013; 8 (6): e66317. doi: 10.1371/journal.pone.0066317 23826093
82. Masiero M, Lucchiari C, Mazzocco K, E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tob Res. 2019; 21 (1): 119-126. doi: 10.1093/ntr/nty047 29660034
83. Carpenter MJ, Heckman BW, Wahlquist AE, A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiol Biomarkers Prev. 2017; 26 (12): 1795-1803. doi: 10.1158/1055-9965.EPI-17-0460 29127080
84. Cravo AS, Bush J, Sharma G, A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks. Regul Toxicol Pharmacol. 2016; 81 (suppl 1): S1-S14. doi: 10.1016/j.yrtph.2016.10.003 27769828
85. Lucchiari C, Masiero M, Veronesi G, Benefits of e-cigarettes among heavy smokers undergoing a lung cancer screening program: randomized controlled trial protocol. JMIR Res Protoc. 2016; 5 (1): e21. doi: 10.2196/resprot.4805 26842790
86. Tseng TY, Ostroff JS, Campo A, A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tob Res. 2016; 18 (10): 1937-1943. doi: 10.1093/ntr/ntw017 26783292
87. O'Brien B, Knight-West O, Walker N, Parag V, Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tob Induc Dis. 2015; 13 (1): 5. doi: 10.1186/s12971-015-0030-2 25814920
88. Bullen C, Howe C, Laugesen M. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382 (9905): 1629-1637. doi: 10.1016/S0140-6736(13)61842-5
89. Caponnetto P, Campagna D, Cibella F, Correction: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS ONE. Published 2014. doi: 10.1371/annotation/e12c22d3-a42b-455d-9100-6c7ee45d58d0
90. Hajek P, Phillips-Waller A, Przulj D, A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019; 380 (7): 629-637. doi: 10.1056/NEJMoa1808779 30699054
91. Walker N, Parag V, Verbiest M, Laking G, Laugesen M, Bullen C. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet Respir Med. 2020; 8 (1): 54-64. doi: 10.1016/S2213-2600(19)30269-3 31515173
92. Hajek P, Phillips-Waller A, Przulj D, E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT. Health Technol Assess. 2019; 23 (43): 1-82. doi: 10.3310/hta23430 31434605
93. Lee SH, Ahn SH, Cheong YS. Effect of electronic cigarettes on smoking reduction and cessation in Korean male smokers: a randomized controlled study. J Am Board Fam Med. 2019; 32 (4): 567-574. doi: 10.3122/jabfm.2019.04.180384 31300577
94. Masiero M, Lucchiari C, Mazzocco K, Corrigendum: e-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tob Res. 2020; 22 (4): 594-595. doi: 10.1093/ntr/nty175 30239904
95. Rose G, Hamilton PJ. A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health (1978). 1978; 32 (4): 275-281. doi: 10.1136/jech.32.4.275 370171
96. Rose G, Colwell L. Randomised controlled trial of anti-smoking advice: final (20 year) results. J Epidemiol Community Health. 1992; 46 (1): 75-77. doi: 10.1136/jech.46.1.75 1573365
97. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014;(1): CD000031. 24402784
98. Berlin I, Grangé G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ. 2014; 348: g1622. doi: 10.1136/bmj.g1622 24627552
99. Coleman T, Cooper S, Thornton JG,; Smoking, Nicotine, and Pregnancy (SNAP) Trial Team. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med. 2012; 366 (9): 808-818. doi: 10.1056/NEJMoa1109582 22375972
100. Cooper S, Lewis S, Thornton JG,; Smoking, Nicotine and Pregnancy Trial Team. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy-clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technol Assess. 2014; 18 (54): 1-128. doi: 10.3310/hta18540 25158081
101. Cooper S, Taggar J, Lewis S,; Smoking, Nicotine and Pregnancy (SNAP) Trial Team. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respir Med. 2014; 2 (9): 728-737. doi: 10.1016/S2213-2600(14)70157-2 25127405
102. El-Mohandes AA, Windsor R, Tan S, Perry DC, Gantz MG, Kiely M. A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers. Matern Child Health J. 2013; 17 (5): 897-906. doi: 10.1007/s10995-012-1069-9 22761006
103. Essex HN, Parrott S, Wu Q, Li J, Cooper S, Coleman T. Cost-effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomized controlled trial (SNAP). Nicotine Tob Res. 2015; 17 (6): 636-642. doi: 10.1093/ntr/ntu258 25481916
104. Iyen B, Vaz LR, Taggar J, Cooper S, Lewis S, Coleman T. Is the apparently protective effect of maternal nicotine replacement therapy (NRT) used in pregnancy on infant development explained by smoking cessation? secondary analyses of a randomised controlled trial. BMJ Open. 2019; 9 (7): e024923. doi: 10.1136/bmjopen-2018-024923 31300493
105. Oncken C, Dornelas E, Greene J, Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol. 2008; 112 (4): 859-867. doi: 10.1097/AOG.0b013e318187e1ec 18827129
106. Oncken C, Dornelas EA, Kuo C-L, Randomized trial of nicotine inhaler for pregnant smokers. Am J Obstet Gynecol MFM. 2019; 1 (1): 10-18. doi: 10.1016/j.ajogmf.2019.03.006 31380506
107. Pollak KI, Oncken CA, Lipkus IM, Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med. 2007; 33 (4): 297-305. doi: 10.1016/j.amepre.2007.05.006 17888856
108. Vaz LR, Coleman T, Cooper S, Aveyard P, Leonardi-Bee J; SNAP Trial Team. The nicotine metabolite ratio in pregnancy measured by trans-3'-hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine Tob Res. 2015; 17 (11): 1318-1323. doi: 10.1093/ntr/ntu342 25589677
109. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000; 96 (6): 967-971. doi: 10.1097/00006250-200012000-00019 11084187
110. Bérard A, Zhao JP, Sheehy O. Success of smoking cessation interventions during pregnancy. Am J Obstet Gynecol. 2016; 215 (5): 611.e1-611.e8. doi: 10.1016/j.ajog.2016.06.059 27402053
111. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Nicotine replacement therapy in pregnancy and major congenital anomalies in offspring. Pediatrics. 2015; 135 (5): 859-867. doi: 10.1542/peds.2014-2560 25847803
112. Dhalwani NN, Szatkowski L, Coleman T, Fiaschi L, Tata LJ. Stillbirth among women prescribed nicotine replacement therapy in pregnancy: analysis of a large UK pregnancy cohort. Nicotine Tob Res. 2019; 21 (4): 409-415. doi: 10.1093/ntr/nty019 29394405
113. Pedersen L, Petronis KR, Nørgaard M, Risk of adverse birth outcomes after maternal varenicline use: a population-based observational study in Denmark and Sweden. Pharmacoepidemiol Drug Saf. 2020; 29 (1): 94-102. doi: 10.1002/pds.4894 31713302
114. Tran DT, Preen DB, Einarsdottir K, Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Med. 2020; 18 (1): 15. doi: 10.1186/s12916-019-1472-9 32019533
115. Zhu JL, Olsen J, Liew Z, Li J, Niclasen J, Obel C. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics. 2014; 134 (2): e382-e388. doi: 10.1542/peds.2014-0213 25049343
116. Anthenelli RM, Benowitz NL, West R, Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016; 387 (10037): 2507-2520. doi: 10.1016/S0140-6736(16)30272-0 27116918
117. Claire R, Chamberlain C, Davey MA, Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020; 3: CD010078. doi: 10.1002/14651858.CD010078.pub3 32129504
118. Krishnasamy VP, Hallowell BD, Ko JY,; Lung Injury Response Epidemiology/Surveillance Task Force. Update: characteristics of a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury-United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (3): 90-94. doi: 10.15585/mmwr.mm6903e2 31971931
119. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. National Academies Press; 2018.
120. Wang TW, Asman K, Gentzke AS, Tobacco product use among adults-United States, 2017. MMWR Morb Mortal Wkly Rep. 2018; 67 (44): 1225-1232. doi: 10.15585/mmwr.mm6744a2 30408019